JP2023540664A5 - - Google Patents
Info
- Publication number
- JP2023540664A5 JP2023540664A5 JP2022581404A JP2022581404A JP2023540664A5 JP 2023540664 A5 JP2023540664 A5 JP 2023540664A5 JP 2022581404 A JP2022581404 A JP 2022581404A JP 2022581404 A JP2022581404 A JP 2022581404A JP 2023540664 A5 JP2023540664 A5 JP 2023540664A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- composition
- composition according
- methyl
- topical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063046531P | 2020-06-30 | 2020-06-30 | |
| US63/046,531 | 2020-06-30 | ||
| PCT/US2021/039646 WO2022006129A1 (en) | 2020-06-30 | 2021-06-29 | Irak4 inhibitors and topical uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540664A JP2023540664A (ja) | 2023-09-26 |
| JP2023540664A5 true JP2023540664A5 (cg-RX-API-DMAC7.html) | 2024-06-26 |
| JP7813733B2 JP7813733B2 (ja) | 2026-02-13 |
Family
ID=79315566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581404A Active JP7813733B2 (ja) | 2020-06-30 | 2021-06-29 | Irak4阻害剤及びそれらの局所的使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230390265A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4172163A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7813733B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116134038A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021300110A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022027086A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186630A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298929A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022006129A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3159624A1 (en) * | 2019-11-05 | 2021-05-14 | Dermira, Inc. | Topical compositions comprising irak4 inhibitors for use in treating dermatological conditions characterised by inflammation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101741294B1 (ko) * | 2010-05-28 | 2017-05-29 | 히사미쓰 세이야꾸 가부시키가이샤 | 미소 돌기가 형성된 어레이를 갖는 디바이스 |
| CA2929316C (en) * | 2013-11-08 | 2021-12-28 | Takeda Pharmaceutical Company Limited | Pyrazole for the treatment autoimmune disorders |
| TW201825095A (zh) * | 2016-11-28 | 2018-07-16 | 德商艾庫里斯抗感染治療有限公司 | 包含n-[5-(胺基磺醯基)-4-甲基-1,3-噻唑-2-基]-n-甲基-2-[4-(2-吡啶基)-苯基]-乙醯胺之局部醫藥調配物 |
| WO2018129364A1 (en) * | 2017-01-06 | 2018-07-12 | Palvella Therapeutics Llc | Anhydrous compositions of mtor inhibitors and methods of use |
| WO2019143971A2 (en) * | 2018-01-18 | 2019-07-25 | Sienna Biopharmaceuticals, Inc. | Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure |
| KR20200138730A (ko) * | 2018-03-29 | 2020-12-10 | 루모사 테라퓨틱스 캄파니 리미티드 | 가려움증 치료용 조성물 및 방법 |
| US20210260055A1 (en) * | 2018-06-21 | 2021-08-26 | Dermavant Sciences GmbH | Topical formulations of dgat1 inhibitors and their methods of use |
| US20200038392A1 (en) * | 2018-08-03 | 2020-02-06 | Aldeyra Therapeutics, Inc. | Topical compositions and methods of preparation and use |
| CA3159624A1 (en) * | 2019-11-05 | 2021-05-14 | Dermira, Inc. | Topical compositions comprising irak4 inhibitors for use in treating dermatological conditions characterised by inflammation |
-
2021
- 2021-06-29 IL IL298929A patent/IL298929A/en unknown
- 2021-06-29 EP EP21832337.6A patent/EP4172163A4/en active Pending
- 2021-06-29 CA CA3186630A patent/CA3186630A1/en active Pending
- 2021-06-29 US US18/007,950 patent/US20230390265A1/en active Pending
- 2021-06-29 CN CN202180057708.9A patent/CN116134038A/zh active Pending
- 2021-06-29 JP JP2022581404A patent/JP7813733B2/ja active Active
- 2021-06-29 WO PCT/US2021/039646 patent/WO2022006129A1/en not_active Ceased
- 2021-06-29 AU AU2021300110A patent/AU2021300110A1/en active Pending
- 2021-06-29 BR BR112022027086A patent/BR112022027086A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10960006B2 (en) | Topical formulations comprising tofacitinib | |
| US7868044B2 (en) | Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid | |
| JP2779303B2 (ja) | 水系ゲルのレチノイド服用形態 | |
| US20100158993A1 (en) | Topical Gel Compositions | |
| RU2637408C2 (ru) | Содержащие ретиноид композиции для местного применения типа эмульсии "масло в воде" | |
| EP1858503B1 (en) | Topical gels compositions | |
| US8815953B2 (en) | Formulations of vitamin K analogs for topical use | |
| AU2016287636B2 (en) | Diacerein or rhein topical formulations and uses thereof | |
| EP2874619B1 (fr) | Compositions pharmaceutiques topiques de type émulsion h/e contenant un rétinoïde | |
| WO2022109626A1 (en) | Gel, ointment, and foam formulations of tapinarof and methods of use | |
| EP2854803B1 (fr) | Compositions topiques sous forme de gel contenant un rétinoïde particulier solubilisé | |
| WO2013036830A1 (en) | Topical itraconazole formulations and uses thereof | |
| EP2854801B1 (fr) | Compositions topiques de type gel aqueux sous forme de suspension homogène d'un principe actif de la classe des rétinoïdes contenant au moins une silice hydrophobe | |
| ZA200707357B (en) | Detection of very virulent infectious bursal disease virus | |
| CN101151028A (zh) | 局部用凝胶组合物 | |
| JPWO2009041714A1 (ja) | フリーラジカル性疾患用外用剤 | |
| WO2026067901A1 (zh) | 一种局部药物组合物 | |
| EP4467159A1 (en) | (4r)-3-(4-fluoro-2-hydroxyphenyl)-4-methyl-4,5-dihydro-1hpyrazole- 1-carboximidamide hydrochloride and dermal formulations thereof | |
| US20180021290A1 (en) | Diacerein or rhein topical formulations and uses thereof | |
| HK1119058A (en) | Topical gels compositions | |
| JP2007502799A (ja) | ラベンダスチンの医薬組成物 |